Pharmabiz7h
Theriva Biologics announces positive outcome of DSMC review in phase 1b/2a trial of ribaxamase in allogeneic HCT recipients
Rockville, Maryland Saturday, October 5, 2024, 18:00 Hrs [IST] ...
Pharmabiz11h
Bavarian Nordic joins global efforts to fight mpox outbreak in Africa
Bavarian Nordic A/S, a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines, announced an extended commitment to help fight the current mpox outbreak ...
Pharmabiz11h
Soligenix partners with Sterling Pharma to optimize and implement a commercially viable, scalable production technology for synthetic hypericin
Soligenix partners with Sterling Pharma to optimize and implement a commercially viable, scalable production technology for synthetic hypericin: Princeton, New Jersey Saturday, Oc ...
Pharmabiz9h
Panacell Biotech’s exosome manufacturing method patent registered as original technology
Panacell Biotech’s exosome manufacturing method patent registered as original technology: Seoul, South Korea Saturday, October 5, 2024, 16:00 Hrs [IST] Panacell Biotech Co, Ltd.
Pharmabiz10h
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases: Geneva Saturday, October 5, 2024, 15:00 Hrs [IST] The World Health Organization ...
Pharmabiz8h
Palvella Therapeutics awarded up to $2.6 mn grant from US FDA OOPD to support phase 3 SELVA trial in in microcystic lymphatic malformations
Wayne, Pennsylvania Saturday, October 5, 2024, 17:00 Hrs [IST] ...
Pharmabiz10h
Recipharm strengthens pharmaceutical development capabilities with strategic investments
Recipharm strengthens pharmaceutical development capabilities with strategic investments: Stockholm, Sweden Saturday, October 5, 2024, 15:30 Hrs [IST] Recipharm, a leading global ...
Pharmabiz12h
Shape Therapeutics introduces advances in AI-powered platform for precision RNA editing
Shape Therapeutics introduces advances in AI-powered platform for precision RNA editing: Seattle Saturday, October 5, 2024, 13:00 Hrs [IST] Shape Therapeutics, a leader in RNA-bas ...
Pharmabiz15h
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer: Tokyo Saturday, October 5, 2024, 10:00 Hrs [IST] Daiich ...
Pharmabiz14h
Halozyme expands global collaboration and license agreement with argenx for ENHANZE
Halozyme Therapeutics, Inc., a biopharmaceutical company, announced that argenx has nominated four new targets under its global collaboration and license agreement that provides argenx exclusive ...
Pharmabiz16h
WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use
WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use: Geneva Saturday, October 5, 2024, 09:00 Hrs [IST] The World Health Organization (WH ...
Pharmabiz17h
India’s pool of pharmacognosists needs to take up leadership roles: Dr DBA Narayana
India’s pool of pharmacognosists needs to take up leadership roles: Dr DBA Narayana: Nandita Vijayasimha, Bengaluru Saturday, October 5, 2024, 08:00 Hrs [IST] India’s pool of ...